Panel Members

Take surveys and earn points as a member of the YouGov panel.

Register

Business

Access YouGov products and services as a business.

Register

Panel Members

Take surveys and earn points as a member of the YouGov panel.

Log in

Business

Access YouGov products and services as a business.

Log in

Business inquiries

We'll email you back within 24 hours.

Get in touch

General inquiries

For member enquiries, public data requests, or general questions.

Contact usor visit Member helpdesk
Should pharmaceutical companies be required to license COVID‑19 treatments to generic drug makers? Published on November 19, 2021 → Survey conducted on November 19, 2021 on 4776 U.S. adults
42%
19%
39%
By:
42%
19%
39%
Related topics

Published on the same day

Which of the following comes closest to your view about COVID-19 vaccines' effect on the chance of getting infected?

See results

How many Thanksgiving celebrations will you attend this year?

See results

Explore more opinion data

Sector favorability: Pharmaceuticals & biotech

Tracker

How Halodoc strengthened its market position in a post-COVID Indonesia with YouGov

Article

Forever young? U.S. anti-aging report 2026

Article

Spring allergy season is underway and it’s reshaping the OTC aisle

Article

Brand pain points: Tracking Tylenol’s consumer performance through a turbulent year

Article

How fitness brands can reach weight-management-focused consumers in the US

Article

How Americans buy hair care – Three key insights brands need to know

Article

Where beauty ads land: the channels regular make-up users in the U.S. notice this holiday season

Article

Half of Americans believe aliens have visited Earth

Article